UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future

The Lancet (British edition), 2014-03, Vol.383 (9922), p.1068-1083

2014

Volltextzugriff (PDF)

Early beta cell dysfunction vs insulin hypersecretion as the primary event in the pathogenesis of dysglycaemia

Diabetologia, 2020-10, Vol.63 (10), p.2007-2021

2020

Volltextzugriff (PDF)

COVID-19, Hyperglycemia, and New-Onset Diabetes

Diabetes care, 2021-12, Vol.44 (12), p.2645-2655

2021

Volltextzugriff (PDF)

Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study

The Lancet (British edition), 2012-06, Vol.379 (9833), p.2243-2251

2012

Volltextzugriff (PDF)

Incretin therapy and islet pathology: a time for caution

Diabetes (New York, N.Y.), 2013-07, Vol.62 (7), p.2178-2180

Kahn, Steven E

2013

Volltextzugriff (PDF)

Rationale and Design of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE)

Diabetes care, 2013-08, Vol.36 (8), p.2254-2261

2013

Volltextzugriff (PDF)

Update and Next Steps for Real-World Translation of Interventions for Type 2 Diabetes Prevention: Reflections From a Diabetes Care Editors' Expert Forum

Diabetes care, 2016-07, Vol.39 (7), p.1186-1201

2016

Volltextzugriff (PDF)

Impaired Glucose and Insulin Homeostasis in Moderate-Severe CKD

Journal of the American Society of Nephrology, 2016-09, Vol.27 (9), p.2861-2871

2016

Volltextzugriff (PDF)

Ghrelin Suppresses Glucose-Stimulated Insulin Secretion and Deteriorates Glucose Tolerance in Healthy Humans

Diabetes (New York, N.Y.), 2010-09, Vol.59 (9), p.2145-2151

2010

Volltextzugriff (PDF)

Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy

The New England journal of medicine, 2006-12, Vol.355 (23), p.2427-2443

2006

Volltextzugriff (PDF)

Differences in A1C by Race and Ethnicity Among Patients With Impaired Glucose Tolerance in the Diabetes Prevention Program

Diabetes care, 2007-10, Vol.30 (10), p.2453-2457

2007

Volltextzugriff (PDF)

Design and baseline characteristics of the CARdiovascular Outcome Trial of LINAgliptin Versus Glimepiride in Type 2 Diabetes (CAROLINA®)

Diabetes & vascular disease research, 2015-05, Vol.12 (3), p.164-174

2015

Volltextzugriff (PDF)

Islet amyloid formation is an important determinant for inducing islet inflammation in high-fat-fed human IAPP transgenic mice

Diabetologia, 2014-09, Vol.57 (9), p.1884-1888

2014

Volltextzugriff (PDF)

Effects of weight loss, weight cycling, and weight loss maintenance on diabetes incidence and change in cardiometabolic traits in the Diabetes Prevention Program

Diabetes care, 2014-10, Vol.37 (10), p.2738-2745

2014

Volltextzugriff (PDF)

Oral Disposition Index Predicts the Development of Future Diabetes Above and Beyond Fasting and 2-h Glucose Levels

Diabetes care, 2009-02, Vol.32 (2), p.335-341

2009

Volltextzugriff (PDF)

Optimum BMI cut points to screen asian americans for type 2 diabetes

Diabetes care, 2015-05, Vol.38 (5), p.814-820

2015

Volltextzugriff (PDF)

Increased Visceral Adipose Tissue Is an Independent Predictor for Future Development of Atherogenic Dyslipidemia

The journal of clinical endocrinology and metabolism, 2016-02, Vol.101 (2), p.678-685

2016

Volltextzugriff (PDF)

Low Plasma Adiponectin Concentrations Predict Increases in Visceral Adiposity and Insulin Resistance

The journal of clinical endocrinology and metabolism, 2017-12, Vol.102 (12), p.4626-4633

2017

Volltextzugriff (PDF)

Change in Visceral Adiposity Independently Predicts a Greater Risk of Developing Type 2 Diabetes Over 10 Years in Japanese Americans

Diabetes care, 2013-02, Vol.36 (2), p.289-293

2013

Volltextzugriff (PDF)

A Call for Improved Reporting of Human Islet Characteristics in Research Articles

Diabetes (New York, N.Y.), 2019-02, Vol.68 (2), p.239-240

2019

Volltextzugriff (PDF)

Islet Amyloid: A Critical Entity in the Pathogenesis of Type 2 Diabetes

The journal of clinical endocrinology and metabolism, 2004-08, Vol.89 (8), p.3629-3643

2004

Volltextzugriff (PDF)

Patterns of Insulin Concentration During the OGTT Predict the Risk of Type 2 Diabetes in Japanese Americans

Diabetes care, 2013-05, Vol.36 (5), p.1229-1235

2013

Volltextzugriff (PDF)

Regression From Pre-Diabetes to Normal Glucose Regulation in the Diabetes Prevention Program

Diabetes care, 2009-09, Vol.32 (9), p.1583-1588

2009

Volltextzugriff (PDF)

Complex Distribution, Not Absolute Amount of Adiponectin, Correlates with Thiazolidinedione-mediated Improvement in Insulin Sensitivity

The Journal of biological chemistry, 2004-03, Vol.279 (13), p.12152-12162

2004

Volltextzugriff (PDF)

Elevated Depression Symptoms, Antidepressant Medicine Use, and Risk of Developing Diabetes During the Diabetes Prevention Program

Diabetes care, 2008-03, Vol.31 (3), p.420-426

2008

Volltextzugriff (PDF)

1 – 25 von 898

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(858)
Mit Volltextzugriff
(809)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(556)
Life Sciences & Biomedicine
(517)
Humans
(490)
Male
(304)
Female
(297)
Endocrinology & Metabolism
(284)
Diabetes
(273)
Middle Aged
(229)
Biological And Medical Sciences
(217)
Medical Sciences
(182)
Adult
(181)
Insulin
(152)
Diabetes Mellitus
(150)
Glucose
(139)
Aged
(136)
Endocrinopathies
(120)
Insulin Resistance
(120)
Endocrine Pancreas. Apud Cells
(111)
Diabetes. Impaired Glucose Tolerance
(110)
Risk Factors
(106)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(11)

Menü

Weitere Dienste

Einstellungen

Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future

Early beta cell dysfunction vs insulin hypersecretion as the primary event in the pathogenesis of dysglycaemia

COVID-19, Hyperglycemia, and New-Onset Diabetes

Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study

Incretin therapy and islet pathology: a time for caution

Rationale and Design of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE)

Update and Next Steps for Real-World Translation of Interventions for Type 2 Diabetes Prevention: Reflections From a Diabetes Care Editors' Expert Forum

Impaired Glucose and Insulin Homeostasis in Moderate-Severe CKD

Ghrelin Suppresses Glucose-Stimulated Insulin Secretion and Deteriorates Glucose Tolerance in Healthy Humans

Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy

Differences in A1C by Race and Ethnicity Among Patients With Impaired Glucose Tolerance in the Diabetes Prevention Program

Design and baseline characteristics of the CARdiovascular Outcome Trial of LINAgliptin Versus Glimepiride in Type 2 Diabetes (CAROLINA®)

Islet amyloid formation is an important determinant for inducing islet inflammation in high-fat-fed human IAPP transgenic mice

Effects of weight loss, weight cycling, and weight loss maintenance on diabetes incidence and change in cardiometabolic traits in the Diabetes Prevention Program

Oral Disposition Index Predicts the Development of Future Diabetes Above and Beyond Fasting and 2-h Glucose Levels

Optimum BMI cut points to screen asian americans for type 2 diabetes

Increased Visceral Adipose Tissue Is an Independent Predictor for Future Development of Atherogenic Dyslipidemia

Low Plasma Adiponectin Concentrations Predict Increases in Visceral Adiposity and Insulin Resistance

Change in Visceral Adiposity Independently Predicts a Greater Risk of Developing Type 2 Diabetes Over 10 Years in Japanese Americans

A Call for Improved Reporting of Human Islet Characteristics in Research Articles

Islet Amyloid: A Critical Entity in the Pathogenesis of Type 2 Diabetes

Patterns of Insulin Concentration During the OGTT Predict the Risk of Type 2 Diabetes in Japanese Americans

Regression From Pre-Diabetes to Normal Glucose Regulation in the Diabetes Prevention Program

Complex Distribution, Not Absolute Amount of Adiponectin, Correlates with Thiazolidinedione-mediated Improvement in Insulin Sensitivity

Elevated Depression Symptoms, Antidepressant Medicine Use, and Risk of Developing Diabetes During the Diabetes Prevention Program

Suchergebnisse filtern